Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ustekinumab
Related studies linked through entity extraction aliases.
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
- Status
- COMPLETED
- Phase
- PHASE3
Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
- Status
- COMPLETED
- Phase
- PHASE4
A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
- Status
- UNKNOWN
- Phase
- PHASE4
Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- Status
- RECRUITING
- Phase
- N/A
BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
- Status
- COMPLETED
- Phase
- N/A
Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
- Status
- TERMINATED
- Phase
- PHASE3
P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
- Status
- TERMINATED
- Phase
- PHASE3
Swiss Dermatology Network of Targeted Therapies (SDNTT)
- Status
- RECRUITING
- Phase
- N/A
A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE2
Ustekinumab for Active Sight-Threatening Uveitis
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
- Status
- UNKNOWN
- Phase
- PHASE4
The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment
- Status
- COMPLETED
- Phase
- PHASE4